食管癌

National Cancer Institute. Esophageal cancer prevention - health professional version (PDQ®). March 2017. http://www.cancer.gov/ (last accessed 7 August 2017).

• 全文

Society for Surgery of the Alimentary Tract. SSAT patient care guidelines: surgical treatment of esophageal cancer. J Gastrointest Surg. 2007;11:1216-1218.

• 全文
• 摘要

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers. 2017. http://www.nccn.org/ (last accessed 7 August 2017).

• 全文

van Hagen P, Hulshof MC, van Lanschot JJ, et al; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-2084.

• 全文
• 摘要

Shapiro J, van Lanschot JJ, Hulshof MC, et al; CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090-1098.

• 摘要

Sharma P, Kozarek R; Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010;105:258-273.

• 全文
• 摘要

1.  Demeester SR. Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res. 2009;3(2 suppl 1):S2-S5.

• 全文
• 摘要

2.  American Cancer Society. Cancer facts & figures. 2014. http://www.cancer.org/ (last accessed 24 October 2016).

• 全文

3.  Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg. 2002;74:278-284.

• 摘要

4.  Lagergren J. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis? Best Pract Res Clin Gastroenterol. 2006;20:803-812.

• 摘要

5.  Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645-654.

• 全文
• 摘要

6.  Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17:2-9.

• 摘要

7.  Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184-1187.

• 全文
• 摘要

8.  Baquet CR, Commiskey P, Mack K, et al. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2005;97:1471-1478.

• 全文
• 摘要

9.  Schulmann K, Sterian A, Berki A, et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene. 2005;24:4138-4148.

• 摘要

10.  Merry AH, Schouten LJ, Goldbohm RA, et al. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56:1503-1511.

• 全文
• 摘要

11.  Kamangar F, Chow WH, Abnet CC, et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38:27-57.

• 摘要

12.  Bjelakovic G, Nikolova D, Simonetti RG, et al. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008;(3):CD004183.

• 摘要

13.  Salaspuro MP. Alcohol consumption and cancer of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2003;17:679-694.

• 摘要

14.  Messman H. Squamous cell cancer of the oesophagus. Best Pract Res Clin Gastroenterol. 2001;15:249-265.

• 摘要

15.  Lu XM, Monnier-Benoit S, Mo LZ, et al. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol. 2008;34:765-770.

• 摘要

16.  Lagergren J, Bergstrom R, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 2000;85:340-346.

• 摘要

17.  Graham JP, Leibler JH, Price LB, et al. The animal-human interface and infectious disease in industrial food animal production: rethinking biosecurity and biocontainment. Public Health Rep. 2008;123:282-299.

• 全文
• 摘要

18.  Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus. 2002;15:106-108.

• 摘要

19.  Cossentino MJ, Wong RK. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis. 2003;14:128-135.

• 摘要

20.  Reed MF, Tolis G Jr, Edil BH, et al. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005;79:1110-1115.

• 摘要

21.  Selaru FM, Zou T, Xu Y, et al. Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene. 2002;21:475-478.

• 全文
• 摘要

22.  Bull LM, White DL, Bray M, et al. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009;22:571-587.

• 摘要

23.  Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049-1057.

• 摘要

24.  Garavello W, Negri E, Talamini R, et al. Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14:1390-1393.

• 全文
• 摘要

25.  Dai L, Wang K, Zhang J, et al. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: a meta-analysis of case-control studies. Int J Cancer. 2009;125:1102-1109.

• 摘要

26.  Islami F, Boffetta P, Ren JS, et al. High-temperature beverages and foods and esophageal cancer risk - a systematic review. Int J Cancer. 2009;125:491-524.

• 摘要

27.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Volume 90: human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636.

• 全文
• 摘要

28.  Zhang DH. Meta-analysis of relationship between tumorigenesis of esophageal carcinoma and human papillomavirus infection. World Chin J Digestol. 2009;17:1130-1134.

• 全文

29.  Oesophagus. In: World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: The Institute; 1997:118-129.

30.  Corley DA, Kerlikowske K, Verma R, et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003;124:47-56.

• 摘要

31.  Alexandre L, Clark AB, Cheong E, et al. Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma. 2012;36:301-311.

• 摘要

32.  National Cancer Institute. Esophageal cancer prevention - health professional version (PDQ®). March 2017. http://www.cancer.gov/ (last accessed 7 August 2017).

• 全文

33.  Ebright M, Krasna M. Overview: esophageal and proximal stomach malignancy. In: Sugarbaker DJ, ed. Adult chest surgery: concepts and procedures. New York, NY: McGraw-Hill; 2009:chapter 10.

34.  Dunbar KB, Okolo P 3rd, Montgomery E, et al. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc. 2009;70:645-654.

• 摘要

35.  Curvers WL, Herrero LA, Wallace MB, et al. Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus. Gastroenterology. 2010;139:1106-1114.

• 摘要

36.  Lefor AT, Merino MM, Steinberg SM, et al. Computerized tomographic prediction of extraluminal spread and prognostic implications of lesion width in esophageal carcinoma. Cancer. 1988;62:1287-1292.

• 摘要

37.  Dave UR, Williams AD, Wilson JA, et al. Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology. 2004;230:281-286.

• 摘要

38.  Wong R, Walker-Dilks C, Raifu A. Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer. Clin Oncol (R Coll Radiol). 2012;24:86-104.

• 摘要

39.  Kwee RM. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review. Radiology. 2010;254:707-717.

• 摘要

40.  Rebollo Aguirre AC, Ramos-Font C, Villegas PR, et al. 18F-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer: systematic review of the literature. Ann Surg. 2009;250:247-254.

• 摘要

41.  Javeri H, Xiao L, Rohren E, et al. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer. 2009;115:5184-5192.

• 摘要

42.  Lordick F. Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography. Recent Results Cancer Res. 2012;196:201-211.

• 摘要

43.  Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202-3210.

• 摘要

44.  Chen YM, Pan XF, Tong LJ, et al. Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis. Nucl Med Commun. 2011;32:1005-1010.

• 摘要

45.  Zhu W, Xing L, Yue J, et al. Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation: a systematic review and meta-analysis. Br J Radiol. 2012;85:e694-e701.

• 摘要

46.  Puli SR, Reddy JB, Bechtold ML, et al. Accuracy of endoscopic ultrasound in the diagnosis of distal and celiac axis lymph node metastasis in esophageal cancer: a meta-analysis and systematic review. Dig Dis Sci. 2008;53:2405-2414.

• 摘要

47.  Boyce HW Jr. Endosonographic staging of esophageal cancer. Cancer Control. 1999;6:28-35.

• 摘要

48.  Chang KJ, Katz KD, Durbin TE, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc. 1994;40:694-699.

• 摘要

49.  Krasna MJ, Flowers JL, Attar S, et al. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg. 1996;111:800-807.

• 摘要

50.  Krasna MJ, Reed CE, Niedzwiecki D, et al. CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. Ann Thorac Surg. 2001;71:1073-1079.

• 摘要

51.  Dagnini G, Caldironi MW, Marin G, et al. Laparoscopy in abdominal staging of esophageal carcinoma: report of 369 cases. Gastrointest Endosc. 1986;32:400-402.

• 摘要

52.  Chang L, Stefanidis D, Richardson WS, et al. The role of staging laparoscopy for intraabdominal cancers: an evidence-based review. Surg Endosc. 2009;23:231-241.

• 摘要

53.  Mezhir JJ, Shah MA, Jacks LM, et al. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17:3173-3180.

• 摘要

54.  Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-1474.

• 摘要

55.  Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours. 7th ed. Oxford, UK: Wiley-Blackwell; 2009.

56.  Ishwaran H, Blackstone EH, Apperson-Hansen C, et al. A novel approach to cancer staging: application to esophageal cancer. Biostatistics. 2009;10:603-620.

• 摘要

57.  Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22:1-8.

• 摘要

58.  Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46-50.

• 摘要

59.  Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607-1619.

• 摘要

60.  Hirst NG, Gordon LG, Whiteman DC, et al. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. J Gastroenterol Hepatol. 2011;26:247-254.

• 摘要

61.  Fernando HC, Murthy SC, Hofstetter W, et al. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg. 2009;87:1993-2002.

• 摘要

62.  Wolf WA, Pasricha S, Cotton C, et al. Incidence of esophageal adenocarcinoma and causes of mortality after radiofrequency ablation of Barrett's esophagus. Gastroenterology. 2015;149:1752-1761.e1.

• 摘要

63.  Bolton WD, Hofstetter WL, Francis AM, et al. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009;138:831-836.

• 摘要

64.  Rice TW, Zuccaro G Jr, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787-792.

• 摘要

65.  Society for Surgery of the Alimentary Tract. SSAT patient care guidelines: surgical treatment of esophageal cancer. J Gastrointest Surg. 2007;11:1216-1218.

• 全文
• 摘要

66.  Jamieson GG, Thompson SK. Detection of lymph node metastases in oesophageal cancer. Br J Surg. 2009;96:21-25.

• 摘要

67.  Krasna MJ. Multimodality therapy for esophageal cancer: how to approach this disease in the absence of level 1 evidence. In: American Society of Clinical Oncology: ASCO Educational Book 2009. Alexandria, VA: American Society of Clinical Oncology; 2009:240-242.

• 全文

68.  Kranzfelder M, Büchler P, Lange K, et al. Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature. J Am Coll Surg. 2010;210:351-359.

• 摘要

69.  Phoa KN, Pouw RE, Bisschops R, et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of a European multicentre study (EURO-II). Gut. 2016;65:555-562.

• 摘要

70.  National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers. 2017. http://www.nccn.org/ (last accessed 7 August 2017).

• 全文

71.  Bizekis C, Kent MS, Luketich JD, et al. Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg. 2006;82:402-407.

• 摘要

72.  Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256:95-103.

• 全文
• 摘要

73.  Butler N, Collins S, Memon B, et al. Minimally invasive oesophagectomy: current status and future direction. Surg Endosc. 2011;25:2071-2083.

• 摘要

74.  Brooke BS, Meguid RA, Makary MA, et al. Improving surgical outcomes through adoption of evidence-based process measures: intervention specific or associated with overall hospital quality? Surgery. 2010;147:481-490.

• 摘要

75.  Skipworth RJ, Parks RW, Stephens NA, et al. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003. Eur J Surg Oncol. 2010;36:141-147.

• 摘要

76.  Boudourakis LD, Wang TS, Roman SA, et al. Evolution of the surgeon-volume, patient-outcome relationship. Ann Surg. 2009;250:159-165.

• 摘要

77.  Yasunaga H, Matsuyama Y, Ohe K, et al. Effects of hospital and surgeon case-volumes on postoperative complications and length of stay after esophagectomy in Japan. Surg Today. 2009;39:566-571.

• 摘要

78.  Ellis FH Jr, Watkins E Jr, Krasna MJ, et al. Staging of carcinoma of the esophagus and cardia: a comparison of different staging criteria. J Surg Oncol. 1993;52:231-235.

• 摘要

79.  Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg. 2007;246:363-374.

• 全文
• 摘要

80.  Yannopoulos P, Theodoridis P, Manes K. Esophagectomy without thoracotomy: 25 years of experience over 750 patients. Langenbecks Arch Surg. 2009;394:611-616.

• 全文
• 摘要

81.  Dai JG, Zhang ZY, Min JX, et al. Wrapping of the omental pedicle flap around esophagogastric anastomosis after esophagectomy for esophageal cancer. Surgery. 2011;149:404-410.

• 摘要

82.  Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1000.

• 摘要

83.  Donohoe CL, O'Farrell NJ, Ravi N, et al. Evidence-based selective application of transhiatal esophagectomy in a high-volume esophageal center. World J Surg. 2012;36:98-103.

• 摘要

84.  Krasna M, Moainie S. Left transthoracic esophagectomy (C Format). In: Sugarbaker DJ, ed. Adult chest surgery: concepts and procedures. New York, NY: McGraw Hill; 2009:chapter 20.

85.  Boshier PR, Anderson O, Hanna GB. Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: a meta-analysis. Ann Surg. 2011;254:894-906.

• 摘要

86.  Kurokawa Y, Sasako M, Sano T, et al; Japan Clinical Oncology Group (JCOG9502). Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg. 2015;102:341-348.

• 全文
• 摘要

87.  Li B, Xiang J, Zhang Y, et al. Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial. JAMA Surg. 2015;150:292-298.

• 摘要

88.  Kim RH, Takabe K. Methods of esophagogastric anastomoses following esophagectomy for cancer: a systematic review. J Surg Oncol. 2010;101:527-533.

• 摘要

89.  Yuan Y, Zeng X, Hu Y, et al. Omentoplasty for oesophagogastrostomy after oesophagectomy. Cochrane Database Syst Rev. 2014;(10):CD008446.

• 全文
• 摘要

90.  Kayani B, Jarral OA, Athanasiou T, et al. Should oesophagectomy be performed with cervical or intrathoracic anastomosis? Interact Cardiovasc Thorac Surg. 2012;14:821-826.

• 全文
• 摘要

91.  Scarpa M, Valente S, Alfieri R, et al. Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol. 2011;17:4660-4674.

• 全文
• 摘要

92.  al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15:277-284.

• 摘要

93.  Weigel TL, Frumiento C, Gaumintz E. Endoluminal palliation for dysphagia secondary to esophageal carcinoma. Surg Clin North Am. 2002;82:747-761.

• 摘要

94.  Chen M, Pennathur A, Luketich JD. Role of photodynamic therapy in unresectable esophageal and lung cancer. Lasers Surg Med. 2006;38:396-402.

• 摘要

95.  Overholt BF, Wang KK, Burdick JS, et al; International Photodynamic Group for High-Grade Dysplasia in Barrett's Esophagus. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc. 2007;66:460-468.

• 摘要

96.  Greenwald BD, Dumot JA, Horwhat JD, et al. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus. 2010;23:13-19.

• 全文
• 摘要

97.  Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014;(10):CD005048.

• 全文
• 摘要

98.  Gockel I, Sgourakis G, Lyros O, et al. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-384.

• 摘要

99.  Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.

• 全文
• 摘要

100.  Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086-1092.

• 全文
• 摘要

101.  van Hagen P, Hulshof MC, van Lanschot JJ, et al; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-2084.

• 全文
• 摘要

102.  Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-730.

• 全文
• 摘要

103.  Lv J, Cao XF, Zhu B, et al. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol. 2010;16:1649-1654.

• 全文
• 摘要

104.  Cao XF, He XT, Ji L, et al. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus. 2009;22:477-481.

• 摘要

105.  Jin HL, Zhu H, Ling TS, et al. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol. 2009;15:5983-5991.

• 全文
• 摘要

106.  Lv J, Cao XF, Zhu B, et al. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol. 2009;15:4962-4968.

• 全文
• 摘要

107.  Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687-697.

• 摘要

108.  Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27:851-856.

• 全文
• 摘要

109.  Kachnic LA, Winter K, Wasserman T, et al. Longitudinal quality-of-life analysis of RTOG 94-05 (Int 0123): a phase III trial of definitive chemoradiotherapy for esophageal cancer. Gastrointest Cancer Res. 2011;4:45-52.

• 全文
• 摘要

110.  Rodriguez CP, Adelstein DJ, Rice TW, et al. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer. J Thorac Oncol. 2010;5:229-235.

• 摘要

111.  Schreiber D, Rineer J, Vongtama D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol. 2010;5:244-250.

• 摘要

112.  Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681-692.

• 摘要

113.  Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727-1733.

• 摘要

114.  Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979-1984.

• 全文
• 摘要

115.  Cunningham D, Allum WH, Stenning SP, et al; MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.

• 全文
• 摘要

116.  Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161-167.

• 全文
• 摘要

117.  Kidane B, Coughlin S, Vogt K, et al. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev. 2015;(5):CD001556.

• 全文
• 摘要

118.  Shapiro J, van Lanschot JJ, Hulshof MC, et al; CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090-1098.

• 摘要

119.  Ku GY, Ilson DH. Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus. Gastrointest Cancer Res. 2012;5:85-92.

• 全文
• 摘要

120.  Ronellenfitsch U, Schwarzbach M, Hofheinz R, et al; GE Adenocarcinoma Meta‐analysis Group. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database Syst Rev. 2013;(5):CD008107.

• 全文
• 摘要

121.  van Olphen SH, Biermann K, Shapiro J, et al. P53 and SOX2 protein expression predicts esophageal adenocarcinoma in response to neoadjuvant chemoradiotherapy. Ann Surg. 2016 Jan 15 [Epub ahead of print].

• 摘要

122.  Al-Batran SE, Ajani JA. Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer. Cancer. 2010;116:2511-2518.

• 全文
• 摘要

123.  Sharma P, Kozarek R; Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010;105:258-273.

• 全文
• 摘要

124.  Diamantis G, Scarpa M, Bocus P, et al. Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol. 2011;17:144-150.

• 全文
• 摘要

125.  Cancer Care Ontario. Preoperative or postoperative therapy for resectable esophageal cancer. June 2016. http://www.cancercare.on.ca/ (last accessed 7 August 2017).

• 全文

126.  Okines AF, Norman AR, McCloud P, et al. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann Oncol. 2009;20:1529-1534.

• 摘要

127.  Ajani JA, Rodriguez W, Bodoky G, et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J Clin Oncol. 2010;28:1547-1553.

• 摘要

128.  Ruurda JP, van der Sluis PC, van der Horst S, et al. Robot-assisted minimally invasive esophagectomy for esophageal cancer: a systematic review. J Surg Oncol. 2015;112:257-265.

• 摘要

129.  Clark J, Sodergren MH, Purkayastha S, et al. The role of robotic assisted laparoscopy for oesophagogastric oncological resection; an appraisal of the literature. Dis Esophagus. 2011;24:240-250.

• 摘要

130.  Lu J, Cao X. A prospective study: intraoperative 125I radioactive seed implant therapy in advanced esophageal squamous cell carcinoma. J Nanjing Med Univ. 2009;23:335-339.

131.  Robb WB, Messager M, Dahan L, et al; Fédération Francophone de Cancérologie Digestive; Société Française de Radiothérapie Oncologique; Union des Centres de Lutte Contre le Cancer; Groupe Coopérateur Multidisciplinaire en Oncologie; French EsoGAstric Tumour working group - Fédération de Recherche En Chirurgie. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone. Br J Surg. 2016;103:117-125.

• 摘要

132.  Cooke DT, Lin GC, Lau CL, et al. Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection. Ann Thorac Surg. 2009;88:177-185.

• 摘要

133.  D'Journo XB, Martin J, Ferraro P, et al. The esophageal remnant after gastric interposition. Dis Esophagus. 2008;21:377-388.

• 摘要